Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Inagaki

Showing results (121-130 of 290) with videos related to

Pageof 29
Sort By:
European Neurology|August 31, 2001
Propriospinal negative myoclonusY Okuma, K Fujishima, Y Machida, et al.
The Journal of Biological Chemistry|April 22, 1994
Synaptotagmin III is a novel isoform of rat synaptotagmin expressed in endocrine and neuronal cellsM Mizuta, N Inagaki, Y Nemoto, et al.
FEBS Letters|November 28, 1994
Somatostatin receptor subtype SSTR2 mediates the inhibition of high-voltage-activated calcium channels by somatostatin and its analogue SMS 201-995Y Fujii, T Gonoi, Y Yamada, et al.
Molecular Human Reproduction|November 1, 1996
Egg activation induced by osmotic pressure change and the effects of amiloride on the cryopreservation of mouse oocytesN Inagaki, S Suzuki, N Kuji, et al.
Diabetes, Obesity & Metabolism|June 21, 2013
Efficacy and safety of canagliflozin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, 12-week studyN Inagaki, K Kondo, T Yoshinari, et al.
The American Journal of Physiology|May 1, 1997
Involvement of MAP kinase and c-fos signaling in the inhibition of cell growth by somatostatinH Yoshitomi, Y Fujii, M Miyazaki, et al.
Diabetes, Obesity & Metabolism|July 17, 2015
Efficacy and safety of once-weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once-daily insulin glargine in Japanese patients with type 2 diabetes: a randomized, open-label, phase III, non-inferiority studyE Araki, N Inagaki, Y Tanizawa, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|December 19, 2000
Development and characterization of 1C6-203, a new monoclonal antibody specific to human thymidine phosphorylaseT Kono, M Nishida, N Inagaki, et al.
European Journal of Pharmacology|March 17, 1999
Participation of histamine H1 and H2 receptors in passive cutaneous anaphylaxis-induced scratching behavior in ICR miceN Inagaki, N Nakamura, M Nagao, et al.
Biochemical and Biophysical Research Communications|December 30, 1994
Hamster gastric inhibitory polypeptide receptor expressed in pancreatic islets and clonal insulin-secreting cells: its structure and functional propertiesK Yasuda, N Inagaki, Y Yamada, et al.
Pageof 29

Showing results (121-130 of 290) with videos related to

Sort By:
Pageof 29
European Neurology|August 31, 2001
Propriospinal negative myoclonusY Okuma, K Fujishima, Y Machida, et al.
The Journal of Biological Chemistry|April 22, 1994
Synaptotagmin III is a novel isoform of rat synaptotagmin expressed in endocrine and neuronal cellsM Mizuta, N Inagaki, Y Nemoto, et al.
FEBS Letters|November 28, 1994
Somatostatin receptor subtype SSTR2 mediates the inhibition of high-voltage-activated calcium channels by somatostatin and its analogue SMS 201-995Y Fujii, T Gonoi, Y Yamada, et al.
Molecular Human Reproduction|November 1, 1996
Egg activation induced by osmotic pressure change and the effects of amiloride on the cryopreservation of mouse oocytesN Inagaki, S Suzuki, N Kuji, et al.
Diabetes, Obesity & Metabolism|June 21, 2013
Efficacy and safety of canagliflozin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, 12-week studyN Inagaki, K Kondo, T Yoshinari, et al.
The American Journal of Physiology|May 1, 1997
Involvement of MAP kinase and c-fos signaling in the inhibition of cell growth by somatostatinH Yoshitomi, Y Fujii, M Miyazaki, et al.
Diabetes, Obesity & Metabolism|July 17, 2015
Efficacy and safety of once-weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once-daily insulin glargine in Japanese patients with type 2 diabetes: a randomized, open-label, phase III, non-inferiority studyE Araki, N Inagaki, Y Tanizawa, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|December 19, 2000
Development and characterization of 1C6-203, a new monoclonal antibody specific to human thymidine phosphorylaseT Kono, M Nishida, N Inagaki, et al.
European Journal of Pharmacology|March 17, 1999
Participation of histamine H1 and H2 receptors in passive cutaneous anaphylaxis-induced scratching behavior in ICR miceN Inagaki, N Nakamura, M Nagao, et al.
Biochemical and Biophysical Research Communications|December 30, 1994
Hamster gastric inhibitory polypeptide receptor expressed in pancreatic islets and clonal insulin-secreting cells: its structure and functional propertiesK Yasuda, N Inagaki, Y Yamada, et al.
Pageof 29